Related references
Note: Only part of the references are listed.Probiotic Clostridium butyricum ameliorated motor deficits in a mouse model of Parkinson's disease via gut microbiota-GLP-1 pathway
Jing Sun et al.
BRAIN BEHAVIOR AND IMMUNITY (2021)
Effects of Helicobacter pylori on Levodopa Pharmacokinetics
Dag Nyholm et al.
JOURNAL OF PARKINSONS DISEASE (2021)
The impact of indigenous microbes on Parkinson's disease
Timothy Sampson
NEUROBIOLOGY OF DISEASE (2020)
The gut microbiome in neurological disorders
John F. Cryan et al.
LANCET NEUROLOGY (2020)
The pharmacological management of constipation in patients with Parkinson's disease: a much-needed relief
Shilan Mozaffari et al.
EXPERT OPINION ON PHARMACOTHERAPY (2020)
State-of-the-art pharmacotherapy for autonomic dysfunction in Parkinson's disease
Cecilia Quarracino et al.
EXPERT OPINION ON PHARMACOTHERAPY (2020)
Gastrointestinal dysfunction in Parkinson's disease
Michal Lubomski et al.
JOURNAL OF NEUROLOGY (2020)
Gut-seeded α-synuclein fibrils promote gut dysfunction and brain pathology specifically in aged mice
Collin Challis et al.
NATURE NEUROSCIENCE (2020)
Factors associated with hospitalisation among people with Parkinson's disease - A systematic review and meta-analysis
Olaitan Okunoye et al.
PARKINSONISM & RELATED DISORDERS (2020)
被撤回的出版物: Gut Microbiome Signatures of Risk and Prodromal Markers of Parkinson Disease (Retracted article. See vol. 90, pg. 329, 2021)
Sebastian Heinzel et al.
ANNALS OF NEUROLOGY (2020)
The Influence of Small Intestinal Bacterial Overgrowth in Digestive and Extra-Intestinal Disorders
Giuseppe Losurdo et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Microbiota Composition and Metabolism Are Associated With Gut Function in Parkinson's Disease
Mihai S. Cirstea et al.
MOVEMENT DISORDERS (2020)
Probiotics Alleviate the Progressive Deterioration of Motor Functions in a Mouse Model of Parkinson's Disease
Tsung-Hsun Hsieh et al.
BRAIN SCIENCES (2020)
Clinical implications of gastric complications on levodopa treatment in Parkinson's disease
Ronald F. Pfeiffer et al.
PARKINSONISM & RELATED DISORDERS (2020)
Brain-first versus body-first Parkinson's disease: a multimodal imaging case-control study
Jacob Horsager et al.
BRAIN (2020)
Meta-Analysisof Gut Dysbiosis in Parkinson's Disease
Hiroshi Nishiwaki et al.
MOVEMENT DISORDERS (2020)
Helicobacter pyloriEradication in Parkinson's Disease: A Randomized Placebo-Controlled Trial
Ai Huey Tan et al.
MOVEMENT DISORDERS (2020)
No enhanced (p-) α-synuclein deposition in gastrointestinal tissue of Parkinson's disease patients
Biyan Nathanael Harapan et al.
PARKINSONISM & RELATED DISORDERS (2020)
The risk of Parkinson's disease in inflammatory bowel disease: A systematic review and meta-analysis
Feng Zhu et al.
DIGESTIVE AND LIVER DISEASE (2019)
Transneuronal Propagation of Pathologic α-Synuclein from the Gut to the Brain Models Parkinson's Disease
Sangjune Kim et al.
NEURON (2019)
Discovery and inhibition of an interspecies gut bacterial pathway for Levodopa metabolism
Vayu Maini Rekdal et al.
SCIENCE (2019)
Multiple Beneficial Effects of Ghrelin Agonist, HM01 on Homeostasis Alterations in 6-Hydroxydopamine Model of Parkinson's Disease in Male Rats
Artem Minalyan et al.
FRONTIERS IN INTEGRATIVE NEUROSCIENCE (2019)
Colonic transit, high-resolution anorectal manometry and MRI defecography study of constipation in Parkinson's disease
Eduardo De Pablo-Fernandez et al.
PARKINSONISM & RELATED DISORDERS (2019)
The Intestinal Barrier in Parkinson's Disease: Current State of Knowledge
Sven C. D. van IJzendoorn et al.
JOURNAL OF PARKINSONS DISEASE (2019)
Increasing Comparability and Utility of Gut Microbiome Studies in Parkinson's Disease: A Systematic Review
Jeffrey M. Boertien et al.
JOURNAL OF PARKINSONS DISEASE (2019)
Effect of Diet on the Gut Microbiota: Rethinking Intervention Duration
Emily R. Leeming et al.
NUTRIENTS (2019)
Role of TLR4 in the gut-brain axis in Parkinson's disease: a translational study from men to mice
Paula Perez-Pardo et al.
GUT (2019)
Update on treatments for nonmotor symptoms of Parkinson's disease-an evidence-based medicine review
Klaus Seppi et al.
MOVEMENT DISORDERS (2019)
Gut-brain axis and the spread of α-synuclein pathology: Vagal highway or dead end?
David P. Breen et al.
MOVEMENT DISORDERS (2019)
Gut bacterial tyrosine decarboxylases restrict levels of levodopa in the treatment of Parkinson's disease
Sebastiaan P. van Kessel et al.
NATURE COMMUNICATIONS (2019)
Diet in Parkinson's Disease: Critical Role for the Microbiome
Aeja Jackson et al.
FRONTIERS IN NEUROLOGY (2019)
Gastric dysmotility in Parkinson's disease is not caused by alterations of the gastric pacemaker cells
Konstantin G. Heimrich et al.
NPJ PARKINSONS DISEASE (2019)
How Does Parkinson's Disease Begin? Perspectives on Neuroanatomical Pathways, Prions, and Histology
Per Borghammer
MOVEMENT DISORDERS (2018)
The Nasal and Gut Microbiome in Parkinson's Disease and Idiopathic Rapid Eye Movement Sleep Behavior Disorder
Anna Heintz-Buschart et al.
MOVEMENT DISORDERS (2018)
Neuroprotective effects of fecal microbiota transplantation on MPTP-induced Parkinson's disease mice: Gut microbiota, glial reaction and TLRLI/TNF-α signaling pathway
Meng-Fei Sun et al.
BRAIN BEHAVIOR AND IMMUNITY (2018)
In-vivo staging of pathology in REM sleep behaviour disorder: a multimodality imaging case-control study
Karoline Knudsen et al.
LANCET NEUROLOGY (2018)
Inoculation of α-synuclein preformed fibrils into the mouse gastrointestinal tract induces Lewy body-like aggregates in the brainstem via the vagus nerve
Norihito Uemura et al.
MOLECULAR NEURODEGENERATION (2018)
Neuropathology of Autonomic Dysfunction in Synucleinopathies
Elizabeth A. Coon et al.
MOVEMENT DISORDERS (2018)
Small intestinal bacterial overgrowth in Parkinson's disease: Tribulations of a trial
Joaquin A. Vizcarra et al.
PARKINSONISM & RELATED DISORDERS (2018)
Fecal markers of intestinal inflammation and intestinal permeability are elevated in Parkinson's disease
Andreas Schwiertz et al.
PARKINSONISM & RELATED DISORDERS (2018)
Helicobacter pylori infection is associated with an increased risk of Parkinson's disease: A population-based retrospective cohort study
Huei-Kai Huang et al.
PARKINSONISM & RELATED DISORDERS (2018)
Functional variants in the LRRK2 gene confer shared effects on risk for Crohn's disease and Parkinson's disease
Ken Y. Hui et al.
SCIENCE TRANSLATIONAL MEDICINE (2018)
Parkinson disease with constipation: clinical features and relevant factors
Qiu-Jin Yu et al.
SCIENTIFIC REPORTS (2018)
Stomaching the Possibility of a Pathogenic Role for Helicobacter pylori in Parkinson's Disease
David J. McGee et al.
JOURNAL OF PARKINSONS DISEASE (2018)
Anti-Tumor Necrosis Factor Therapy and Incidence of Parkinson Disease Among Patients With Inflammatory Bowel Disease
Inga Peter et al.
JAMA NEUROLOGY (2018)
Imaging the Autonomic Nervous System in Parkinson's Disease
Karoline Knudsen et al.
CURRENT NEUROLOGY AND NEUROSCIENCE REPORTS (2018)
A gut-brain neural circuit for nutrient sensory transduction
Melanie Maya Kaelberer et al.
SCIENCE (2018)
Gastrointestinal Dysfunction in Parkinson's Disease
Ronald F. Pfeiffer
CURRENT TREATMENT OPTIONS IN NEUROLOGY (2018)
The vermiform appendix impacts the risk of developing Parkinson's disease
Bryan A. Killinger et al.
SCIENCE TRANSLATIONAL MEDICINE (2018)
Peripheral Inflammation Enhances Microglia Response and Nigral Dopaminergic Cell Death in an in vivo MPTP Model of Parkinson's Disease
Irene Garcia-Dominguez et al.
FRONTIERS IN CELLULAR NEUROSCIENCE (2018)
Management of constipation in patients with Parkinson's disease
Anna J. Pedrosa Carrasco et al.
NPJ PARKINSONS DISEASE (2018)
Constipation in Parkinson's Disease: Subjective Symptoms, Objective Markers, and New Perspectives
Karoline Knudsen et al.
MOVEMENT DISORDERS (2017)
Meta-analysis: Association of Helicobacter pylori infection with Parkinson's diseases
Xiaoli Shen et al.
HELICOBACTER (2017)
Epidemiology of Parkinson's disease
Ole-Bjorn Tysnes et al.
JOURNAL OF NEURAL TRANSMISSION (2017)
Non-motor features of Parkinson disease
Anthony H. V. Schapira et al.
NATURE REVIEWS NEUROSCIENCE (2017)
Vagotomy and Parkinson disease A Swedish register-based matched-cohort study
Bojing Liu et al.
NEUROLOGY (2017)
Decreased intestinal acetylcholinesterase in early Parkinson disease
Tatyana D. Fedorova et al.
NEUROLOGY (2017)
Distinct pattern of enteric phospho-alpha-synuclein aggregates and gene expression profiles in patients with Parkinson's disease
Martina Barrenschee et al.
ACTA NEUROPATHOLOGICA COMMUNICATIONS (2017)
Open Label Trial of the Efficacy and Safety Profile of Rikkunshito used for the Treatment of Gastrointestinal Symptoms in Patients with Parkinson's Disease: A Pilot Study
Koji Yakabi et al.
CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL (2017)
α-Synuclein in gut endocrine cells and its implications for Parkinson's disease
Rashmi Chandra et al.
JCI INSIGHT (2017)
Delayed Gastric Emptying in Advanced Parkinson Disease Correlation With Therapeutic Doses
Alberto Bestetti et al.
CLINICAL NUCLEAR MEDICINE (2017)
Pathological α-Synuclein in Gastrointestinal Tissues from Prodromal Parkinson Disease Patients
Morten Gersel Stokholm et al.
ANNALS OF NEUROLOGY (2016)
Gut Microbiota Regulate Motor Deficits and Neuroinflammation in a Model of Parkinson's Disease
Timothy R. Sampson et al.
CELL (2016)
Appendectomy in mid and later life and risk of Parkinson's disease: A population-based study
Connie Marras et al.
MOVEMENT DISORDERS (2016)
Appendectomy and Risk of Parkinson's Disease: A Nationwide Cohort Study With More Than 10 Years of Follow-Up
Elisabeth Svensson et al.
MOVEMENT DISORDERS (2016)
Serum immune markers and disease progression in an incident Parkinson's disease cohort (ICICLE-PD)
Caroline H. Williams-Gray et al.
MOVEMENT DISORDERS (2016)
Probiotics and prebiotic fiber for constipation associated with Parkinson disease: An RCT
Michela Barichella et al.
NEUROLOGY (2016)
Short chain fatty acids and gut microbiota differ between patients with Parkinson's disease and age-matched controls
Marcus M. Unger et al.
PARKINSONISM & RELATED DISORDERS (2016)
Vagotomy and Subsequent Risk of Parkinson's Disease
Elisabeth Svensson et al.
ANNALS OF NEUROLOGY (2015)
The treatment of gastroparesis, constipation and small intestinal bacterial overgrowth syndrome in patients with Parkinson's disease
Jose L. Barboza et al.
EXPERT OPINION ON PHARMACOTHERAPY (2015)
Neuroepithelial circuit formed by innervation of sensory enteroendocrine cells
Diego V. Bohorquez et al.
JOURNAL OF CLINICAL INVESTIGATION (2015)
Prediagnostic presentations of Parkinson's disease in primary care: a case-control study
Anette Schrag et al.
LANCET NEUROLOGY (2015)
Gastrointestinal dysfunction in Parkinson's disease
Alfonso Fasano et al.
LANCET NEUROLOGY (2015)
Appendectomy May Delay Parkinson's Disease Onset
Alexandre Mendes et al.
MOVEMENT DISORDERS (2015)
Enteric nervous system α-synuclein immunoreactivity in idiopathic REM sleep behavior disorder
Fabienne S. Sprenger et al.
NEUROLOGY (2015)
Helicobacter pylori infection is associated with worse severity of Parkinson's disease
Ai Huey Tan et al.
PARKINSONISM & RELATED DISORDERS (2015)
Structural alterations of the intestinal epithelial barrier in Parkinson's disease
Thomas Clairembault et al.
ACTA NEUROPATHOLOGICA COMMUNICATIONS (2015)
Accumulation of α-synuclein in the bowel of patients in the pre-clinical phase of Parkinson's disease
David Hilton et al.
ACTA NEUROPATHOLOGICA (2014)
Direct evidence of Parkinson pathology spread from the gastrointestinal tract to the brain in rats
Staffan Holmqvist et al.
ACTA NEUROPATHOLOGICA (2014)
Pharmacokinetics of Levodopa in Patients With Parkinson Disease and Motor Fluctuations Depending on the Presence of Helicobacter pylori Infection
Ewa Narozanska et al.
CLINICAL NEUROPHARMACOLOGY (2014)
Dietary Herb Extract Rikkunshi-To Ameliorates Gastroparesis in Parkinson's Disease: A Pilot Study
Hirokazu Doi et al.
EUROPEAN NEUROLOGY (2014)
Alpha-Synuclein in the Appendiceal Mucosa of Neurologically Intact Subjects
Madison T. Gray et al.
MOVEMENT DISORDERS (2014)
Delayed Gastric Emptying in Parkinson's Disease
Sarah Marrinan et al.
MOVEMENT DISORDERS (2014)
Progression of Intestinal Permeability Changes and Alpha-Synuclein Expression in a Mouse Model of Parkinson's Disease
Leo P. Kelly et al.
MOVEMENT DISORDERS (2014)
New ghrelin agonist, HM01 alleviates constipation and L-dopa-delayed gastric emptying in 6-hydroxydopamine rat model of Parkinson's disease
H. Karasawa et al.
NEUROGASTROENTEROLOGY AND MOTILITY (2014)
Small intestinal bacterial overgrowth in Parkinson's disease
Ai Huey Tan et al.
PARKINSONISM & RELATED DISORDERS (2014)
Prion-like spreading of pathological α-synuclein in brain
Masami Masuda-Suzukake et al.
BRAIN (2013)
Caudo-rostral brain spreading of α-synuclein through vagal connections
Ayse Ulusoy et al.
EMBO MOLECULAR MEDICINE (2013)
Gastrointestinal manifestations in Parkinson's disease: prevalence and occurrence before motor symptoms
Maria G. Cersosimo et al.
JOURNAL OF NEUROLOGY (2013)
The role of small intestinal bacterial overgrowth in Parkinson's disease
Alfonso Fasano et al.
MOVEMENT DISORDERS (2013)
The gut as a sensory organ
John B. Furness et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2013)
Coadministration of Domperidone Increases Plasma Levodopa Concentration in Patients With Parkinson Disease
Noriko Nishikawa et al.
CLINICAL NEUROPHARMACOLOGY (2012)
Plasma levodopa peak delay and impaired gastric emptying in Parkinson's disease
Hirokazu Doi et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2012)
Is alpha-synuclein in the colon a biomarker for premotor Parkinson's Disease? Evidence from 3 cases
Kathleen M. Shannon et al.
MOVEMENT DISORDERS (2012)
Ghrelin prevents levodopa-induced inhibition of gastric emptying and increases circulating levodopa in fasted rats
L. Wang et al.
NEUROGASTROENTEROLOGY AND MOTILITY (2012)
Placebo-controlled trial of lubiprostone for constipation associated with Parkinson disease
W. G. Ondo et al.
NEUROLOGY (2012)
Gastroparesis and Parkinson's disease: A systematic review
Zaid S. Heetun et al.
PARKINSONISM & RELATED DISORDERS (2012)
Environmental toxins trigger PD-like progression via increased alpha-synuclein release from enteric neurons in mice
Francisco Pan-Montojo et al.
SCIENTIFIC REPORTS (2012)
Electrical activity-triggered glucagon-like peptide-1 secretion from primary murine L-cells
G. J. Rogers et al.
JOURNAL OF PHYSIOLOGY-LONDON (2011)
Prevalence of Small Intestinal Bacterial Overgrowth in Parkinson's Disease
Maurizio Gabrielli et al.
MOVEMENT DISORDERS (2011)
Increased Intestinal Permeability Correlates with Sigmoid Mucosa alpha-Synuclein Staining and Endotoxin Exposure Markers in Early Parkinson's Disease
Christopher B. Forsyth et al.
PLOS ONE (2011)
Multi-organ distribution of phosphorylated α-synuclein histopathology in subjects with Lewy body disorders
Thomas G. Beach et al.
ACTA NEUROPATHOLOGICA (2010)
Differential Effect of Helicobacter pylori Eradication on Time-Trends in Brady/Hypokinesia and Rigidity in Idiopathic Parkinsonism
Sylvia M. Dobbs et al.
HELICOBACTER (2010)
Probiotics and the gut microbiota in intestinal health and disease
Melanie G. Gareau et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2010)
Progression of Parkinson's Disease Pathology Is Reproduced by Intragastric Administration of Rotenone in Mice
Francisco Pan-Montojo et al.
PLOS ONE (2010)
Ghrelin receptor agonist (TZP-101) accelerates gastric emptying in adults with diabetes and symptomatic gastroparesis
N. Ejskjaer et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2009)
Major Nutritional Issues in the Management of Parkinson's Disease
Michela Barichella et al.
MOVEMENT DISORDERS (2009)
Medical records documentation of constipation preceding Parkinson disease A case-control study
R. Savica et al.
NEUROLOGY (2009)
Exogenous α-synuclein fibrils seed the formation of Lewy body-like intracellular inclusions in cultured cells
Kelvin C. Luk et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Alpha-synuclein-immunopositive myenteric neurons and vagal preganglionic terminals: Autonomic pathway implicated in Parkinson's disease?
R. J. Phillips et al.
NEUROSCIENCE (2008)
Macrogol for the treatment of constipation in Parkinson's disease. A randomized placebo-controlled study
Roberta Zangaglia et al.
MOVEMENT DISORDERS (2007)
Modulation by high-fat diets of gastrointestinal function and hormones associated with the regulation of energy intake: implications for the pathophysiology of obesity
Tanya J. Little et al.
AMERICAN JOURNAL OF CLINICAL NUTRITION (2007)
Small intestinal bacterial overgrowth: Diagnosis and treatment
Antonio Gasbarrini et al.
DIGESTIVE DISEASES (2007)
Ghrelin stimulates gastric emptying and hunger in normal-weight humans
F. Levin et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2006)
Excess burden of constipation in Parkinson's disease: A pilot study
Julie Kaye et al.
MOVEMENT DISORDERS (2006)
Helicobacter pylori eradication and L-dopa absorption in patients with PD and motor fluctuations
M. Pierantozzi et al.
NEUROLOGY (2006)
Gastric α-synuclein immunoreactive inclusions in Meissner's and Auerbach's plexuses in cases staged for Parkinson's disease-related brain pathology
H Braak et al.
NEUROSCIENCE LETTERS (2006)
Cycad toxins, Helicobacter pylori and parkinsonism: Cholesterol glucosides as the common denomenator
JD Schulz et al.
MEDICAL HYPOTHESES (2006)
Ghrelin enhances gastric emptying in diabetic gastroparesis: a double blind, placebo controlled, crossover study
CDR Murray et al.
GUT (2005)
Increased gastric motility during 5-HT4 agonist therapy reduces response fluctuations in Parkinson's disease
H Asai et al.
PARKINSONISM & RELATED DISORDERS (2005)
Idiopathic Parkinson's disease:: possible routes by which vulnerable neuronal types may be subject to neuroinvasion by an unknown pathogen
H Braak et al.
JOURNAL OF NEURAL TRANSMISSION (2003)
Staging of brain pathology related to sporadic Parkinson's disease
H Braak et al.
NEUROBIOLOGY OF AGING (2003)
Share Paper
